New x-ray contrast agents. The chemical, biological, and physical properties of 5-heterocycle substituted 2,4,6-triiodo-1,3-benzenedicarboxamide derivatives.
Ranganathan
R S
RS
Contrast Media Department, Bristol-Myers Squibb Pharmaceutical Research Institute, New Brunswick, New Jersey.
Arunachalam
T
T
Diamantidis
G
G
Duncan
L
L
Emswiler
J
J
Marinelli
E
E
Neubeck
R
R
Pillai
R
R
Wedeking
P
P
Tweedle
M F
MF
D000818:Animals; D055598:Chemical Phenomena; D002627:Chemistry, Physical; D003287:Contrast Media / Q000737:chemistry* / Q000633:toxicity; D004355:Drug Stability; D004361:Drug Tolerance; D007928:Lethal Dose 50; D008297:Male; D010078:Oxazines / Q000737:chemistry* / Q000633:toxicity; D010880:Piperidines / Q000737:chemistry* / Q000633:toxicity; D011760:Pyrrolidinones / Q000737:chemistry* / Q000633:toxicity; D051381:Rats; D013329:Structure-Activity Relationship; D014283:Triiodobenzoic Acids / Q000737:chemistry* / Q000633:toxicity
D003287:Contrast Media; D010078:Oxazines; D010880:Piperidines; D011760:Pyrrolidinones; D014283:Triiodobenzoic Acids